Federal Circuit Remands CBM Review Decision, Asks PTAB to Explain Meaning of Part One of “Technological Invention” Exception

Oct 14, 2019

Reading Time : 3 min

The ’842 Patent—owned by SIPCO, LLC (SIPCO)—claims a two-step wireless communication system wherein a “low-power” user device wirelessly transmits signal data (e.g., containing a user PIN) to an intermediate node (e.g., an ATM machine), which in turn transmits the data to a central location (e.g., a bank that verifies user PINs). Notably, the specification explains that the “low-power” nature of the user device requires the device to be in close range to the intermediate node, which can alleviate problems such as unwanted interference with the signal data. Emerson Electric Co. (Emerson) requested CBM review of the ’842 Patent on §§ 101 and 103 grounds.

Under the America Invents Act (AIA), a patent is eligible for CBM review if any of its claims cover “performing data processing or other operations used in the practice, administration, or management of a financial product or service.” AIA § 18(d)(1). Exempted from CBM review, however, are “patents for technological inventions.” Id. The AIA does not give a meaning of “technological invention,” but the USPTO regulations provide that a “technological invention” must (1) “recite[] a technological feature that is novel and unobvious over the prior art,” and (2) “solve[] a technical problem using a technical solution.” 37 C.F.R. § 42.301(b). Both parts of the exception must be satisfied to exempt a patent from CBM review.

Applying this framework, the PTAB determined the patent was eligible for CBM review and that the “technological invention” exception did not apply. Analyzing only part two of the exception, the PTAB reasoned that the claims cannot solve a “technical problem” because the problem of “[a]utomating machine service requests” (such as for ATM machines) was financial, not technical. The PTAB further explained that the claimed “solution” was also not “technical” because the claims merely recite “generic and known hardware elements and routine computer functions.” Accordingly, the PTAB instituted CBM review and ultimately determined that the challenged claims were unpatentable under §§ 101 and 103. SIPCO appealed.

On appeal, the Federal Circuit, reversed the PTAB and held that part two of the “technological invention” exception does apply and remanded the decision to the PTAB to assess part one. The Court explained that the PTAB “misread and mischaracterized the features” of the claims and thus “did not appreciate that the claims provide a technical solution to a technical problem.” In particular, the Court held that the PTAB erred by failing to construe the term “low-power” as requiring the claimed devices to wirelessly transmit data at a “limited transmission range,” noting that the “specification explicitly ties the low power transceiver to a limited transmission distance.” Under this construction, the Court explained that the claims provide a specific technical solution (requiring low voltage devices to limit wireless transmission range) that solves technical problems (e.g., unwanted interference due to long-range wireless transmission)—in contrast to claims that merely recite “off-the-shelf” components to address a generic problem.

On remand, the PTAB will be tasked with analyzing—and interpreting—part one of the “technological invention” exception, which requires “a technological feature that is novel and unobvious over the prior art.” The Federal Circuit rejected Emerson’s argument that, by analyzing and finding SIPCO’s patent obvious under § 103, there was no need to assess “unobviousness” under part one of the test. In doing so, the Court questioned “whether it makes sense to interpret the first part of § 42.301(b)—which references the word obvious—as coextensive with § 103. In light of this, the Federal Circuit explicitly asked the PTAB to “explain what part one of the regulation means and then apply it as so explicated.” The Court further noted that “[t]he omission of any definition for the phrase ‘technological invention’ underscores the importance of meaningful guidance from the patent office on § 42.301(b).”

In dissent, Judge Reyna disagreed with the majority’s claim construction but agreed that the decision should be remanded to interpret part one of § 42.301(b)(1).

Practice tip: Practitioners should monitor the ensuing PTAB decision on remand for its interpretation of step one of the “technological invention” exclusion. More generally, in CBM proceedings, practitioners should carefully review claim limitations in light of the specification for any “technical” hooks to the specification that could help avoid CBM review. The case is also a reminder that, although the PTAB’s decision to institute a CBM proceeding is technically “nonappealable,” the Federal Circuit can review the determination of whether the challenged patent is eligible for CBM review.

SIPCO, LLC v. Emerson Electric Co., No. 2018-1635 (Fed. Cir. Sep. 25, 2019)

Share This Insight

Previous Entries

IP Newsflash

November 11, 2025

The Federal Circuit recently vacated a summary judgment ruling of invalidity, holding that the district court erred in applying preclusive effect to the Patent Trial and Appeal Board’s unpatentability findings regarding other claims in the same patent. In doing so, the Federal Circuit reiterated that issue preclusion does not apply where the prior factual determinations were made under a lower standard of proof.

...

Read More

IP Newsflash

November 3, 2025

The Federal Circuit recently clarified the requirement for work disclosed in a reference to qualify as “by another” under pre-AIA Sections 102(a) and (e), holding that there must be complete inventive identity between the information disclosed in the asserted reference and the inventors named on the relevant patent. 

...

Read More

IP Newsflash

October 31, 2025

The District Court for the Northern District of California recently granted a defendant’s motion to bifurcate, ordering that issues related to PGR estoppel should be decided in a bench trial, while the remaining issues in the case should proceed to a jury trial.

...

Read More

IP Newsflash

October 31, 2025

The Northern District of Iowa recently held that a defendant’s motion for partial summary judgment of invalidity was barred after the PTAB issued final written decisions, regardless of when the motion was filed. The defendant filed its motion before the final written decisions were issued, but the court rejected the defendant’s argument that the timing of the motion insulated it from estoppel.

...

Read More

IP Newsflash

October 1, 2025

In a recent final written decision, the PTAB determined that a reference patent was not prior art, despite the petitioner’s post‑filing attempt to correct its petition. While the petitioner argued that it intended to rely on the patent application’s earlier date of publication, both the corrected petition and the expert declaration continued to reference the issued patent rather than the published application.

...

Read More

IP Newsflash

September 30, 2025

The USPTO Director recently granted a petitioner’s request for rehearing of the decision discretionarily denying institution of inter partes review, ultimately vacating the original decision, and referring the petition to the board for an institution decision.

...

Read More

IP Newsflash

September 25, 2025

In considering claims to a method of reducing cardiovascular events, the Federal Circuit held that the term a “clinically proven effective” amount did not render the claims patentable over the prior art. Specifically, the Federal Circuit held that the “clinically proven effective” amount, whether limiting or not, could not be used to distinguish the prior art because the claims also specified the exact amount of the drugs to be administered in the method. The Federal Circuit also rejected patentee’s evidence of unexpected results because that evidence was tied solely to the “clinically proven effective” limitation.

...

Read More

IP Newsflash

September 24, 2025

The Federal Circuit reversed a district court’s denial of judgment as a matter of law on non-infringement, thereby setting aside a $106 million jury verdict, after holding that prosecution history estoppel barred the patentee from asserting infringement under the doctrine of equivalents.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.